1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Li, D. Lu, S. Gu, X. Liang, S. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking H2 N 16.023 AMINO GROUP non-polymer C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US J.Biol.Chem. JBCHA3 0071 0021-9258 279 37734 37740 10.1074/jbc.M405765200 15201273 Structure-Activity Relationships of Hainantoxin-IV and Structure Determination of Active and Inactive Sodium Channel Blockers. 2004 CN Acta Biochim.Biophys.Sinica 0582-9879 34 516 519 Synthesis and Oxidative Refolding of Hainantoxin-Iv 2002 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 1 SINGLE WAVELENGTH M 1 1.0 3999.629 HAINANTOXIN-IV 1 nat polymer HnTx-IV no yes ECLGFGKGCNPSNDQCCKSSNLVCSRKHRWCKYEI(NH2) ECLGFGKGCNPSNDQCCKSSNLVCSRKHRWCKYEIX A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n Ornithoctonus sample 209901 Ornithoctonus hainana VENOM pdbx_struct_assembly pdbx_struct_oper_list struct_conf repository Initial release Version format compliance Version format compliance Derived calculations 1 0 2003-01-14 1 1 2008-04-29 1 2 2011-07-13 1 3 2017-11-29 RCSB Y RCSB 2002-12-30 REL REL THIS STRUCTURE WAS DETERMINED USING STANDARD 2D HOMONUCLEAR TECHNIQUES. structures with the lowest energy 50 20 NOESY DQF-COSY TOCSY 20 4.00 1 atm 288.00 K THE STRUCTURES ARE BASED ON 566 NOE-DERIVED DISTANCE CONSTRAINTS, 14 DIHEDRAL ANGEL RESTRAINTS, 9 FAKE DISTANCE RESTRAINTS FROM DISULFIDE BONDS AND 8 HYDROGEN-BOND CONSTRAINTS. simulated annealing 1 5.5 MM HAINANTOXIN-IV MMOL/L DEUTERIUM ACETIC ACID BU 90%H2O , 10%D2O BRUNGER refinement X-PLOR 3.851 structure solution FELIX 98.0 500 Bruker DRX GLU 1 n 1 GLU 1 A CYS 2 n 2 CYS 2 A LEU 3 n 3 LEU 3 A GLY 4 n 4 GLY 4 A PHE 5 n 5 PHE 5 A GLY 6 n 6 GLY 6 A LYS 7 n 7 LYS 7 A GLY 8 n 8 GLY 8 A CYS 9 n 9 CYS 9 A ASN 10 n 10 ASN 10 A PRO 11 n 11 PRO 11 A SER 12 n 12 SER 12 A ASN 13 n 13 ASN 13 A ASP 14 n 14 ASP 14 A GLN 15 n 15 GLN 15 A CYS 16 n 16 CYS 16 A CYS 17 n 17 CYS 17 A LYS 18 n 18 LYS 18 A SER 19 n 19 SER 19 A SER 20 n 20 SER 20 A ASN 21 n 21 ASN 21 A LEU 22 n 22 LEU 22 A VAL 23 n 23 VAL 23 A CYS 24 n 24 CYS 24 A SER 25 n 25 SER 25 A ARG 26 n 26 ARG 26 A LYS 27 n 27 LYS 27 A HIS 28 n 28 HIS 28 A ARG 29 n 29 ARG 29 A TRP 30 n 30 TRP 30 A CYS 31 n 31 CYS 31 A LYS 32 n 32 LYS 32 A TYR 33 n 33 TYR 33 A GLU 34 n 34 GLU 34 A ILE 35 n 35 ILE 35 A NH2 36 n 36 NH2 36 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 identity operation 0.0000000000 0.0000000000 0.0000000000 A O LYS 7 A O LYS 7 A N CYS 31 A N CYS 31 A N LYS 32 A N LYS 32 A O VAL 23 A O VAL 23 1 A ARG 26 0.314 SIDE CHAIN 1 A ARG 29 0.318 SIDE CHAIN 2 A ARG 26 0.313 SIDE CHAIN 2 A ARG 29 0.305 SIDE CHAIN 3 A ARG 26 0.303 SIDE CHAIN 3 A ARG 29 0.316 SIDE CHAIN 4 A ARG 26 0.318 SIDE CHAIN 4 A ARG 29 0.318 SIDE CHAIN 5 A ARG 26 0.318 SIDE CHAIN 5 A ARG 29 0.317 SIDE CHAIN 6 A ARG 26 0.310 SIDE CHAIN 6 A ARG 29 0.310 SIDE CHAIN 7 A ARG 26 0.312 SIDE CHAIN 7 A ARG 29 0.317 SIDE CHAIN 8 A ARG 26 0.313 SIDE CHAIN 8 A ARG 29 0.293 SIDE CHAIN 9 A ARG 26 0.317 SIDE CHAIN 9 A ARG 29 0.311 SIDE CHAIN 10 A ARG 26 0.316 SIDE CHAIN 10 A ARG 29 0.314 SIDE CHAIN 11 A ARG 26 0.318 SIDE CHAIN 11 A ARG 29 0.313 SIDE CHAIN 12 A ARG 26 0.283 SIDE CHAIN 12 A ARG 29 0.317 SIDE CHAIN 13 A ARG 26 0.316 SIDE CHAIN 13 A ARG 29 0.313 SIDE CHAIN 14 A ARG 26 0.317 SIDE CHAIN 14 A ARG 29 0.314 SIDE CHAIN 15 A ARG 26 0.306 SIDE CHAIN 15 A ARG 29 0.300 SIDE CHAIN 16 A ARG 26 0.310 SIDE CHAIN 16 A ARG 29 0.316 SIDE CHAIN 17 A ARG 26 0.312 SIDE CHAIN 17 A ARG 29 0.309 SIDE CHAIN 18 A ARG 26 0.316 SIDE CHAIN 18 A ARG 29 0.314 SIDE CHAIN 19 A ARG 26 0.317 SIDE CHAIN 19 A ARG 29 0.311 SIDE CHAIN 20 A ARG 26 0.295 SIDE CHAIN 20 A ARG 29 0.305 SIDE CHAIN 1 A CYS 2 -161.05 91.92 1 A ASP 14 62.87 99.04 3 A ASP 14 53.38 74.76 3 A ASN 21 52.40 72.85 6 A CYS 2 61.45 96.46 6 A ASP 14 58.03 80.96 7 A ASP 14 56.43 85.47 8 A CYS 2 60.61 92.30 8 A ASN 13 -116.42 71.97 9 A ASP 14 55.33 87.64 10 A ASP 14 58.18 89.44 12 A ASP 14 58.52 81.71 13 A ASP 14 59.35 87.44 14 A ASP 14 54.07 74.91 15 A CYS 2 58.37 84.11 15 A ASP 14 57.33 80.31 16 A ASP 14 62.29 93.58 17 A ASP 14 53.18 80.15 18 A ASN 13 -110.98 69.34 19 A ASP 14 57.24 84.18 20 A ASP 14 55.64 82.73 HAINANTOXIN-IV THREE DIMENSIONAL SOLUTION STRUCTURE OF HAINANTOXIN-IV BY 2D 1H-NMR 1 N N disulf 2.019 A CYS 2 A SG CYS 2 1_555 A CYS 17 A SG CYS 17 1_555 disulf 2.020 A CYS 9 A SG CYS 9 1_555 A CYS 24 A SG CYS 24 1_555 disulf 2.021 A CYS 16 A SG CYS 16 1_555 A CYS 31 A SG CYS 31 1_555 covale 1.312 A ILE 35 A C ILE 35 1_555 A NH2 36 A N NH2 36 1_555 TOXIN NEUROTOXIN, INHIBITOR CYSTINE KNOT MOTIF, TOXIN TXHA4_SELHA UNP 1 1 P83471 ECLGFGKGCNPSNDQCCKSSNLVCSRKHRWCKYEI 1 35 1NIY 1 35 P83471 A 1 1 35 3 anti-parallel parallel A LYS 7 A LYS 7 A CYS 9 A CYS 9 A TRP 30 A TRP 30 A TYR 33 A TYR 33 A LEU 22 A LEU 22 A SER 25 A SER 25 BINDING SITE FOR RESIDUE NH2 A 36 Software 2 A GLU 34 A GLU 34 2 1_555 A ILE 35 A ILE 35 2 1_555 1 P 1